| 1 |
SAKUMA T, BARRY M, IKEDA Y. Lentiviral vectors: basic to translational[J]. Biochem. J., 2012, 443(3):603-618.
|
| 2 |
HANSEN E, LEE K, MELOTTI S, et al.. Characterization of nanoparticles in lentiviral vector preparations[J/OL]. Mol. Ther., 2016, 24(S1): 280[2023-02-03]. .
|
| 3 |
VORMITTAG P, GUNN R, GHORASHIAN S, et al.. A guide to manufacturing CAR T cell therapies[J]. Curr. Opin. Biotech., 2018, 53: 164-181.
|
| 4 |
POOREBRAHIM M, SADEGHI S, FAKHR E, et al.. Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects[J]. Crit. Rev. Clin. Lab. Sci., 2019, 56(6): 393-419.
|
| 5 |
SENA-ESTEVES M, GAO G. Titration of lentivirus vectors[M]. US: Cold Spring Harbor Laboratory Press, 2018, 281-285.
|
| 6 |
刘圆圆,牛卿,冯晓明.人源化Mesothelin嵌合抗原受体介导的T细胞抗肿瘤效果[J].生物技术进展,2019,9(3):253-261.
|
| 7 |
陈思琪,张松平,杨延丽,等.慢病毒载体定量检测方法的研究进展[J].生物工程学报,2021,37(7):2283-2292.
|
| 8 |
鲍建芳, 沈建根. 免疫学实验技术[M]. 杭州:浙江大学出版社, 2006: 26-28.
|
| 9 |
Validation of Analytical Procedures: Text and Methodology (R1)[S]. International Conference on the Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2005.
|
| 10 |
国家药典委员会.中国药典(2020版)四部:9101分析方法验证指导原则[M].(第十一版).北京:中国医药科技出版社,2020.
|
| 11 |
GERAERTS M, WILLEMS S, BAEKELANDT V, et al.. Comparison of lentiviral vector titration methods[J/OL].BMC Biotechnol., 2006, 6: 34[2022-10-26]..
|
| 12 |
DELENDA C, GAILLARD C. Real-time quantitative PCR for the design of lentiviral vector analytical assays[J].Gene Ther., 2005, 12(S1): 36-S50.
|